CID 139369660

Darizmetinib

Structural Information

Molecular Formula
C21H17F2N5O3S
SMILES
CCCS(=O)(=O)NC1=C(C=CC(=C1F)C(=O)C2=C3C=C(C=NC3=NN2)C4=CC=NC=C4)F
InChI
InChI=1S/C21H17F2N5O3S/c1-2-9-32(30,31)28-19-16(22)4-3-14(17(19)23)20(29)18-15-10-13(11-25-21(15)27-26-18)12-5-7-24-8-6-12/h3-8,10-11,28H,2,9H2,1H3,(H,25,26,27)
InChIKey
WBNMARNYIFMNEP-UHFFFAOYSA-N
Compound name
N-[2,6-difluoro-3-(5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine-3-carbonyl)phenyl]propane-1-sulfonamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

19
Patents

457.10202 Da
Monoisotopic Mass

3.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 458.10930 205.2
[M+Na]+ 480.09124 215.9
[M-H]- 456.09474 208.4
[M+NH4]+ 475.13584 210.7
[M+K]+ 496.06518 207.1
[M+H-H2O]+ 440.09928 193.7
[M+HCOO]- 502.10022 216.0
[M+CH3COO]- 516.11587 212.8
[M+Na-2H]- 478.07669 206.8
[M]+ 457.10147 207.9
[M]- 457.10257 207.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe